72 related articles for article (PubMed ID: 2163237)
1. CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia.
Grotta JC; Picone CM; Ostrow PT; Strong RA; Earls RM; Yao LP; Rhoades HM; Dedman JR
Ann Neurol; 1990 Jun; 27(6):612-9. PubMed ID: 2163237
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism.
Simon R; Shiraishi K
Ann Neurol; 1990 Jun; 27(6):606-11. PubMed ID: 2163236
[TBL] [Abstract][Full Text] [Related]
3. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
Bennett DA; Bernard PS; Amrick CL; Wilson DE; Liebman JM; Hutchison AJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):454-60. PubMed ID: 2547931
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
[TBL] [Abstract][Full Text] [Related]
5. The novel N-methyl-D-aspartate (NMDA) antagonist CGS 19755 prevents ischemia-induced reductions of adenosine A1, NMDA, and PCP receptors in gerbil brain.
Jarvis MF; Murphy DE; Williams M; Gerhardt SC; Boast CA
Synapse; 1988; 2(6):577-84. PubMed ID: 2850632
[TBL] [Abstract][Full Text] [Related]
6. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
7. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
[TBL] [Abstract][Full Text] [Related]
9. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
Boast CA; Pastor G; Gerhardt SC; Hall NR; Liebman JM
J Pharmacol Exp Ther; 1988 Nov; 247(2):556-61. PubMed ID: 2846824
[TBL] [Abstract][Full Text] [Related]
10. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
11. CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties.
Bennett DA; Lehmann J; Bernard PS; Liebman JM; Williams M; Wood PL; Boast CA; Hutchison AJ
Prog Clin Biol Res; 1990; 361():519-24. PubMed ID: 1981269
[TBL] [Abstract][Full Text] [Related]
12. Participation of NMDA-receptors in ischemic changes of calcium homeostasis in rabbit brain.
Salinska E; Pluta R; Lazarewicz JW
Biomed Biochim Acta; 1989; 48(2-3):S170-3. PubMed ID: 2567159
[TBL] [Abstract][Full Text] [Related]
13. Neuronal protection correlates with prevention of calcium-calmodulin binding in rats.
Grotta JC; Picone CM; Dedman JR; Rhoades HM; Strong RA; Earls RM; Yao LP
Stroke; 1990 Nov; 21(11 Suppl):III28-31. PubMed ID: 2237982
[TBL] [Abstract][Full Text] [Related]
14. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.
Winkelheide U; Lasarzik I; Kaeppel B; Winkler J; Werner C; Kochs E; Engelhard K
Acta Anaesthesiol Scand; 2009 Apr; 53(4):528-33. PubMed ID: 19317867
[TBL] [Abstract][Full Text] [Related]
16. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
[TBL] [Abstract][Full Text] [Related]
17. In vitro binding of [3H]nimodipine and [3H]CGS-19755 to rat brain in focal cerebral ischemia.
Hogan MJ; Takizawa S; Hakim AM
Exp Neurol; 1995 Jul; 134(1):56-63. PubMed ID: 7672038
[TBL] [Abstract][Full Text] [Related]
18. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
France CP; Lu Y; Woods JH
J Pharmacol Exp Ther; 1990 Dec; 255(3):1271-7. PubMed ID: 2262905
[TBL] [Abstract][Full Text] [Related]
19. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
Okada M; Ueda H; Kometani M; Nakao K
Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
[TBL] [Abstract][Full Text] [Related]
20. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
Willetts J; Clissold DB; Hartman TL; Brandsgaard RR; Hamilton GS; Ferkany JW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1055-62. PubMed ID: 8099615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
